Hyundai Mobis plans to extend biotech to mobility to take care of the driver's health
SEOUL, South Korea, June 23, 2022 /PRNewswire/ -- Hyundai Mobis (KRX: 012330) has become the world's first to develop an integrated controller that analyzes the driver's vital signs, such as posture, heart rate, and brainwaves, the company announced on 23 June, 2022.
Dubbed the Smart Cabin Controller by the company, this technology consists of four sensors for measuring the vital signs of occupants, a controller to analyze such signs, and software logic. It can be said the company has developed something akin to an advanced brain that can analyze vital signs that change in real time.
While there are already controllers that are capable of processing certain vital signs in the mobility industry, this is the first time for a dedicated healthcare controller to be developed that can perform an integrated analysis of various vital signs. With this new controller, the company is now well on the way to realizing safety technology that is focused on the occupants rather than in terms of vehicle performance.
Hyundai Mobis expects that this dedicated vital signs controller will contribute to enabling the vehicle to play a role as a 'moving health check-up center.' The company plans to preoccupy the market, which is currently in a fledgling state, by ombining this new healthcare technology with mobility. To this end, automotive suppliers are unprecedentedly showing a move toward securing experts in biotech or robotics.
"Our core competitive edge is the software solution that has been designed to apply healthcare to mobility and the controller that enables integrated control," said Cheon Jae-seung, head of the R&D division, Hyundai Mobis. "Based on the unique vital signs database we've built up, we will upgrade this technology further to provide more features, including carsickness prevention, stress management, and the blocking of drunk driving."
The Smart Cabin Controller is equipped with four sensors: a 3D camera that captures the posture of occupants, an ECG sensor mounted on the steering wheel, an ear-set sensor to measure the brainwaves flowing around ears, and an HVAC sensor to measure the temperature/humidity and carbon dioxide level of the cabin. The controller analyzes various vital signs collected from these sensors in real time to help with safe driving.
For example, it recommends switching to the autonomous driving mode if the ECG sensor detects a high stress level in the driver, and it opens windows or switches to the outside-circulation mode if the CO2 level is too high. This technology is expected to further evolve to be able to guide the vehicle to an emergency room in case of an emergency, such as cardiac arrest.
Last year, Hyundai Mobis also became the world's first with its development of the M.Brain, a brainwave-based driver monitoring system, and is globally expanding its sales activities with M.VICS, an autonomous driving cockpit system equipped with various new healthcare technologies, including an ECG sensor, driver monitoring camera, and carsickness reduction technology.
About Hyundai MOBIS
Hyundai Mobis is the global no.7 global automotive supplier, headquartered in Seoul, Korea. Hyundai Mobis has outstanding expertise in sensors, sensor fusion in ECUs and software development for safety control. The company's products also include various components for electrification, brakes, chassis and suspension, steering, airbags, lighting and automotive electronics. Hyundai Mobis operates R&D headquarter in Korea, with 4 technology centers in Germany, China, India and the United States.
For more information, please visit the website at http://www.mobis.co.kr/
SOURCE Hyundai Mobis